Loading...

Loading...

Biotech Industry Struggles to Find Specialized Talent
By Sofía Garduño - Tue, 01/30/2024 - 09:52
Navigating the evolving tech landscape poses challenges for biotech talent acquisition, driven by demand for specialized skills.
https://mexicobusiness.news/tag/biomarin
More Health
Biomarin’s Dwarfism Drug Receives EMA Approval
By Miriam Bello - Fri, 08/27/2021 - 13:18
The European Commission approved the use of Biomarin’s treatment for achondroplasia, one of the most common forms of dwarfism.
Value-Based Healthcare: Industry Endgame
By Miriam Bello - Thu, 02/11/2021 - 09:00
Moving the focus of healthcare from sickness treatment to sustained health demands disruption and structural change.
Non-COVID-19 Treatments, How Are They Progressing?
By Miriam Bello - Tue, 08/25/2020 - 13:49
In healthcare, time is gold. How much longer can patients wait for treatments due to COVID-19?
Pharma Opinions on the “Payment By Results” Model
By Miriam Bello - Fri, 07/03/2020 - 14:06
Pharmaceutical industry leaders share their views on the “payment by results” method to increase healthcare access.
IGSA Medical: Challenging the Status Quo in Healthcare
By - Fri, 09/20/2019 - 09:40
Timely and comprehensive patient care is the central axis for improving quality of life.
Centralized Buying Allows Better Oversight
By - Tue, 03/12/2019 - 18:33
BioMarin Pharmaceuticals is a biotechnology company developing and commercializing innovative biopharmaceuticals for rare genetic diseases.
Orphan Drugs Face Tough Environment
By - Wed, 09/06/2017 - 10:30
Rare diseases are often difficult to treat because developing medications for them is costly for manufacturers